SATLF ZOZO INC

Watchlist

31.400
0.0000.00%

15min DelayClose Dec 17 16:00 ET

9.32BMarket Cap32.64P/E (TTM)

ZOZO INC Key Stats

According to the latest financial report of ZOZO INC, the latest earnings per share (TTM) for the company is 37.41. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: JPY

Quarterly

FCF

Interested in knowing about ZOZO INC's free cash flow? The latest report shows it as 1.97B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: JPY

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ZOZO INC shows that the company's current ratio is 1.90, indicating healthy liquidity.

Currency: JPY

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ZOZO INC, the quick ratio is 1.75, indicating that the company can meet its short-term debt obligations.

Currency: JPY

Quarterly

ROE

Want to learn more about the financial health of ZOZO INC? The latest ROE figure is 14.65%, indicating that the company has stable profitability.

Currency: JPY

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ZOZO INC, the total asset return on investment (ROA) is 7.41%.

Currency: JPY

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check ZOZO INC's latest financial report to see how their gross margin is doing - currently at 93.19%.

Currency: JPY

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ZOZO INC, the net profit margin is 22.05%, which is a good sign for its profitability.

Currency: JPY

Quarterly

Trending US Stocks

Symbol Mini Chart % Chg

DexCom

DXCM

+3.27%

Collegium Pharmaceutical